References
- Jhung MA, Swerdlow D, Olsen SJ, Jernigan D, Biggerstaff M, Kamimoto L, . Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis 2011;52(Suppl 1):S13–26.
- Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, . Influenza-associated deaths among children in the United States, 2003–2004. N Engl J Med 2005;353:2559–67.
- Cox CM, Blanton L, Dhara R, Brammer L, Finelli L. 2009 Pandemic influenza A (H1N1) deaths among children—United States, 2009–2010. Clin Infect Dis 2011;52(Suppl 1):S69–74.
- Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991;87:823–8.
- Okamoto S, Kamiya I, Kishida K, Shimakawa T, Fukui T, Morimoto T. Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatr Infect Dis J 2005;24:575–6.
- Siedler K, Skopnik H. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis. Pediatr Infect Dis J 2010;29:495–8.
- Tamura D, Miura T, Kikuchi Y. Oseltamivir phosphate in infants under 1 year of age with influenza infection. Pediatr Int 2005;47:484.
- Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G, . Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J 2010;29:195–8.
- Pannaraj PS, Tam B, Akan D. Oseltamivir treatment and prophylaxis in a neonatal intensive care unit during a 2009 H1N1 influenza outbreak. J Perinatol 2011;31:487–93.
- Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, . Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis 2011;52 (Suppl 1):S36–43.
- World Health Organization. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. Revised February 2010. Geneva: WHO; 2010.
- Japan Pediatric Society. [A guideline for management of neonates with novel influenza (pandemic A/H1N1 2009) in the early neonatal period] (in Japanese). The Journal of the Japan Pediatric Society 2009;113:1492–4.
- Japan Pediatric Society. [A guideline for management of influenza (including pandemic (H1N1) 2009) in neonates during the early postnatal period in 2010–2011 season] (in Japanese). The Journal of the Japan Pediatric Society 2010;114:2016–8.
- American Academy of Pediatrics. Policy statement— recommendations for prevention and control of influenza in children, 2010–2011. Pediatrics 2010;126:816–26.
- Infectious Disease Surveillance Center. Surveillance report for influenza in Japan, 2007–2011. Japan; 2011. Available at: https://hasseidoko.mhlw.go.jp/Byogentai/Pdf/data2j.pdf (accessed date: 8 January 2012).
- Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 2009; 28:372–5.
- Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME. Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Pediatr (Phila) 2010;49:777–81.
- Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, . Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002; 35:512–7.
- Ukimura A, Izumi T, Matsumori A. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. Circ J 2010;74:2193–9.
- Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198:962–70.
- Aebi T, Weisser M, Bucher E, Hirsch HH, Marsch S, Siegemund M. Co-infection of influenza B and streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis 2010;10:308.
- Hoffman-La Roche. Letter from the Medical Director, Roche Laboratories Inc. Roche Pharmaceuticals; 2003. Available at: http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM169493.pdf (accessed date: 8 January 2012).
- Centers for Disease Control and Prevention. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection—United States, April–August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941–7.